DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Injectable Drug Market (2017-2021 Edition)" report to their offering.
The global injectable drug market has increased at a significant CAGR during 2012-2016 and projections are made that the market would rise tremendously in the next five years i.e. 2017-2021. The growth in the market was driven by patient awareness, increase in per capita drug spending, a rise in the personal disposable income of individuals, etc. The market can be segmented into vaccines, insulin, conventional therapeutics and complex biologics. Of all the segments, complex biologics remains the largest segment of the market with the highest growth rate.
The major growth drivers for the injectable drug market are: rise in cancer incidences & diabetic population, the introduction of new products and increase in biologics & new drugs license approvals. Despite the market is governed by various growth drivers, there are certain challenges faced by the market such as high risk of re-operation or death, injectable drug safety issues and less patient compliance.
Growth of the overall global injectable drug market has been forecasted for the period 2017-2021, taking into consideration the previous growth patterns, the growth drivers and the current and future trends. The competition in the global injectable drug market is stiff and dominated by the big players like Pfizer, Inc. Further, key players of the injectable drug market such as Merck & Co., Inc., Novartis AG and Johnson & Johnson are also profiled with their financial information and respective business strategies.
- Pfizer, Inc.
- Merck & Co., Inc.
- Novartis AG
Johnson & Johnson
Key Topics Covered:
1. Executive Summary
3. Global Market Analysis
4. Competitive Landscape
5. Company Profiling
For more information about this report visit https://www.researchandmarkets.com/research/8k8jdh/global_injectable